Last reviewed · How we verify
NCT04209647
A Comparison of Continuous Moderate Training and Reduced High Intensity Interval Training in Obese Young Adults
NA trial testing REHIT Exercise in Obesity in 24 participants. Completed in 1 August 2019.
1 April 2019
Quick facts
| Lead sponsor | Istinye University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 1 May 2018 |
| Primary completion | 1 April 2019 |
| Estimated completion | 1 August 2019 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- REHIT Exercise
- Continuous Aerobic Exercise
Conditions studied
- Obesity — all drugs for Obesity →
- Exercise — all drugs for Exercise →
- Oxygen Consumption — all drugs for Oxygen Consumption →
Sponsor
Istinye University
Who can join
Adults 18 to 22, female only, with Obesity or Exercise. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Exercise is a key component of obesity management. Obese subjects cannot attend or sustain exercise program because of increased general fatigue, dyspnea and muscle fatigue. And they feel more exertion when comparing with normal weight subjects. Reduced-exertion high-intensity interval training (REHIT) is a alternative method to continuous exercise programs. The investigators aimed comparing metabolic effects of REHIT and continuous exercise in young adults, in this study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04209647
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Istinye University trials
Trials by the same sponsor.
- NCT06963294 — Ketamine and Dexmedetomidine for Delirium in Joint Arthroplasty · NA · not yet recruiting
- NCT07528807 — Exercise, Pain Beliefs, and Activity Patterns in Musculoskeletal Pain · not yet recruiting
- NCT07520981 — Functional Capacity, Subjective Dyspnea and Fatigue in Smokers · not yet recruiting
- NCT07518095 — Serum Bicarbonate and Enteral Feeding Intolerance in Adult ICU: A Prospective Clinical Trial · not yet recruiting
- NCT07483190 — Effectiveness of Thoracoabdominal Nerve Block (M-TAPA) on Postoperative Pain Relief in Laparoscopic Hysterectomy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04209647 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istinye University
- Last refreshed: 30 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04209647.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing